Insulet | PODD - Ebit

Stock Price
349.75
Daily Change
1.32 0.38%
Monthly
14.73%
Yearly
59.61%
Q3 Forecast
345.54

Insulet reported $121.1M in EBIT for its fiscal quarter ending in June of 2025.




Ebit Change Date
Abbott USD 2.07B 105M Jun/2025
Align Technology USD 163.03M 23.69M Jun/2025
AtriCure USD -3820000 2.13M Jun/2025
Avanos Medical USD -53660000 65.46M Jun/2025
Baxter International USD 272M 120M Jun/2025
Becton, Dickinson and Co. USD 979M 379M Jun/2025
Boston Scientific USD 942M 408M Jun/2025
Cardinal Health USD 629M 178M Jun/2025
Cooper Companies USD 177.3M 72.2M Jul/2025
Dexcom USD 245.8M 102.7M Jun/2025
Edwards Lifesciences USD 430.9M 19.6M Jun/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
Globus Medical USD -125953000 224.01M Jun/2025
ICU Medical USD 26.8M 54.29M Jun/2025
Insulet USD 121.1M 32.3M Jun/2025
Integra LifeSciences USD -509910000 498.69M Jun/2025
J&J USD 6.94B 443M Jun/2025
Masimo USD 64.5M 42.4M Jun/2025
Medtronic USD 1.52B 969M Jul/2025
Merit Medical Systems USD 50.15M 18.26M Jun/2025
Roche Holding CHF 11.29B 2.68B Jun/2024
Solventum Corp USD 214M 193M Jun/2025
Stryker USD 1.17B 176M Jun/2025
Tandem Diabetes Care USD -31859000 2.64M Jun/2025
Teleflex USD 156.95M 29.47M Jun/2025
West Pharmaceutical Services USD 153.7M 28.7M Jun/2025
Zimmer Biomet Holdings USD 396.4M 101.2M Jun/2025